by Proactive LTC Consulting | Feb 1, 2023 | COVID-19, MDS, Q&A
Q: Is it appropriate to skill every resident that tests positive for COVID-19? Does the waiver allow us to skill any resident who tests positive? A: There has been quite a bit of confusion surrounding the use of the waivers, especially when it comes to current... by Proactive LTC Consulting | Jan 24, 2023 | MDS, Q&A, Quality Measure
Q: I understand that CMS will be conducting audits of schizophrenia coding in the MDS data and potentially adjusting the long-stay residents who are receiving antipsychotic drugs QM ratings when inaccurate coding is found. What are the criteria for diagnosing... by Proactive LTC Consulting | Jan 18, 2023 | Q&A
Q: How can the facility comply with administering nebulizer treatment without needing to stay with the resident during administration for a resident who will keep nebulizer on? A: In order to support that the resident is able to self-administer a nebulizer... by Proactive LTC Consulting | Jan 10, 2023 | MDS, Q&A
Q: Our facility is being purchased by a new company. Does this affect the current patient’s MDS assessments and schedules? If so, how? A: If the CCN (CMS Certification Number) changes, then yes. Per RAI Chapter 2, pg. 2-5: There are two types of change in... by Proactive LTC Consulting | Jan 4, 2023 | Q&A, Survey
Q: How will the Facility Assessment be used during the survey process? A: During your annual survey, you will be required to provide the survey team a copy of your completed Facility Assessment within four hours of them entering your facility. If systemic care... by Proactive LTC Consulting | Dec 20, 2022 | IPA, PDPM, Q&A
Q: What is the difference between an IPA and a Significant Change Assessment? A: The IPA, which is completed for payment purposes under PDPM is often confused with the SCSA, which is a clinical assessment. The OBRA SCSA is required to be completed when there is...